ProteoPlex GmbH

About ProteoPlex

ProteoPlex is a spin-off company of the Max-Planck-Gesellschaft. The basic technologies behind ProteoPlex were developed at the Max-Planck-Institute of Biophysical Chemistry (MPIBPC) in Goettingen under the leadership of Prof. Dr. Holger Stark and Dr. Ashwin Chari.

Product portfolio of ProteoPlex

Product portfolio

Show all

Bubble-free column packing for pilot scale

Industrial-Scale rAAV Manufacturing with Enhanced Productivity and GMP Compliance

Streamline Your Fill & Finish Operations With Integrated Single-Use Solutions

News about ProteoPlex

28-Mar-2018 | business & finance

NovAliX enters into cooperation agreement with Max-Planck spin-off

NovAliX, a drug discovery-focused Contract Research Organization (CRO) announces that it has signed a cooperation agreement with German-based ProteoPlex ...

Read news

Show more news about ProteoPlex

High-throughput screening of 1536 samples in just 27 seconds: The fastest microplate reader on the market

Real-time PCR thermal cycler qTOWER iris

qTOWER³ auto

Here you will find ProteoPlex GmbH

Last viewed contents

Achlorhydria

Go to page